TREACE MEDICAL CONCEPTS INC (TMCI) Forecast, Price Target & Analyst Ratings

NASDAQ:TMCI • US89455T1097

Current stock price

1.82 USD
-0.05 (-2.67%)
At close:
1.82 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TREACE MEDICAL CONCEPTS INC (TMCI).

Forecast Snapshot

Consensus Price Target

Price Target
$4.08
+ 124.18% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.31
Revenue Estimate
46.879M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
50.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.08
Upside
+ 124.18%
From current price of $1.82 to mean target of $4.08, Based on 10 analyst forecasts
Low
$2.02
Median
$3.06
High
$7.35

Price Target Revisions

1 Month
0.00%
3 Months
-17.31%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for TMCI. The average price target is 4.08 USD. This implies a price increase of 124.18% is expected in the next year compared to the current price of 1.82.
The average price target has been revised downward by 17.31% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TMCI Current Analyst RatingTMCI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

TMCI Historical Analyst RatingsTMCI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
50.00%
TMCI was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about TMCI.
In the previous month the buy percentage consensus was at a similar level.
TMCI was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-02Lake StreetMaintains Buy -> Buy
2026-01-07StifelMaintains Hold -> Hold
2025-12-18Truist SecuritiesMaintains Hold -> Hold
2025-11-10Truist SecuritiesReiterate Hold -> Hold
2025-11-07BTIGDowngrade Buy -> Neutral
2025-11-07UBSMaintains Neutral -> Neutral
2025-11-07JP MorganDowngrade Neutral -> Underweight
2025-10-15Truist SecuritiesMaintains Hold -> Hold
2025-09-04Truist SecuritiesMaintains Hold -> Hold
2025-08-08UBSMaintains Neutral -> Neutral
2025-08-08StifelMaintains Hold -> Hold
2025-05-09UBSMaintains Neutral -> Neutral
2025-04-11Truist SecuritiesMaintains Hold -> Hold
2025-03-13Truist SecuritiesMaintains Hold -> Hold
2025-03-03Truist SecuritiesMaintains Hold -> Hold
2024-12-31Lake StreetInitiate Buy
2024-12-18Truist SecuritiesMaintains Hold -> Hold
2024-11-06StifelMaintains Hold -> Hold
2024-10-14Truist SecuritiesMaintains Hold -> Hold
2024-08-07UBSMaintains Neutral -> Neutral
2024-08-07Truist SecuritiesMaintains Hold -> Hold
2024-07-16Truist SecuritiesMaintains Hold -> Hold
2024-07-15Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2024-05-16UBSDowngrade Buy -> Neutral
2024-05-08BTIGDowngrade Buy -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.31
Revenue Estimate
46.879M
Revenue Q2Q
-10.83%
EPS Q2Q
-25.66%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
0.47%
Revenue (3 Months)
-11.70%
EPS (1 Month)
-6.82%
EPS (3 Months)
-27.45%

Next Earnings Summary

TMCI is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.31 USD and the consensus revenue estimate is 46.88M USD.
The next earnings revenue estimate has been revised downward by 11.7% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
TMCI revenue by date.TMCI revenue by date.
187.118M
31.96%		209.357M
11.89%		212.69M
1.59%		210.04M
-1.25%		227.22M
8.18%		229.5M
1.00%
EBITDA
YoY % growth
TMCI ebitda by date.TMCI ebitda by date.
-46.076M
-41.03%		-47.269M
-2.59%		-43.531M
7.91%		-6.038M
86.13%		-4.49M
25.64%		-9.18M
-104.45%
EBIT
YoY % growth
TMCI ebit by date.TMCI ebit by date.
-51.428M
-47.78%		-55.688M
-8.28%		-54.154M
2.75%		-52.833M
2.44%		-46.986M
11.07%		-45.737M
2.66%
Operating Margin
TMCI operating margin by date.TMCI operating margin by date.
-27.48%-26.60%-25.46%-25.15%-20.68%-19.93%
EPS
YoY % growth
TMCI eps by date.TMCI eps by date.
-0.81
-5.19%		-0.85
-4.94%		-0.94
-10.59%		-0.93
0.82%		-0.86
8.10%		-0.99
-15.48%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.31
-25.66%		-0.30
-6.37%		-0.25
2.71%		-0.07
56.48%		-0.26
17.75%		-0.25
15.52%		-0.22
13.98%		0.00
94.80%		-0.23
9.21%		-0.21
14.87%		-0.20
6.25%		0.01
400.30%
Revenue
Q2Q % growth		46.879M
-10.83%		45.023M
-4.99%		49.144M
-2.13%		69.217M
10.71%		52.418M
11.82%		49.188M
9.25%		53.363M
8.58%		75.626M
9.26%		54.223M
3.44%		51.449M
4.60%		55.202M
3.45%		76.633M
1.33%
EBITDA
Q2Q % growth		-5.557M
57.65%		-5.72M
52.08%		-3.074M
60.89%		8.558M
82.05%		-5.314M
4.37%		-5.93M
-3.66%		-3.784M
-23.09%		9.986M
16.69%		-8.69M
-63.53%		-10.261M
-73.05%		-9.088M
-140.16%		4.07M
-59.24%
EBIT
Q2Q % growth		-19.133M
-22.79%		-18.134M
-6.83%		-15.316M
2.29%		-3.303M
44.23%		-15.579M
18.58%		-15.218M
16.08%		-12.978M
15.27%		737.797K
122.34%		-13.76M
11.68%		-12.587M
17.29%		-11.852M
8.67%		1.805M
144.65%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TMCI Yearly Revenue VS EstimatesTMCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
TMCI Yearly EPS VS EstimatesTMCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-1.72%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
2.00%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
22.59%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TREACE MEDICAL CONCEPTS INC / TMCI Forecast FAQ

What do analysts expect the price target to be for TREACE MEDICAL CONCEPTS INC (TMCI)?

10 analysts have analysed TMCI and the average price target is 4.08 USD. This implies a price increase of 124.18% is expected in the next year compared to the current price of 1.82.

When does TREACE MEDICAL CONCEPTS INC (TMCI) report earnings?

TREACE MEDICAL CONCEPTS INC (TMCI) will report earnings on 2026-05-13, after the market close.

What are the consensus estimates for TREACE MEDICAL CONCEPTS INC (TMCI) next earnings?

The consensus EPS estimate for the next earnings of TREACE MEDICAL CONCEPTS INC (TMCI) is -0.31 USD and the consensus revenue estimate is 46.88M USD.

What is the expected long term growth rate for TREACE MEDICAL CONCEPTS INC (TMCI)?

The expected long term growth rate for TREACE MEDICAL CONCEPTS INC (TMCI) is 2%.